JP2016513638A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513638A5
JP2016513638A5 JP2016500078A JP2016500078A JP2016513638A5 JP 2016513638 A5 JP2016513638 A5 JP 2016513638A5 JP 2016500078 A JP2016500078 A JP 2016500078A JP 2016500078 A JP2016500078 A JP 2016500078A JP 2016513638 A5 JP2016513638 A5 JP 2016513638A5
Authority
JP
Japan
Prior art keywords
combination
peptide
seq
nos
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016500078A
Other languages
English (en)
Japanese (ja)
Other versions
JP6208319B2 (ja
JP2016513638A (ja
Filing date
Publication date
Priority claimed from US13/843,883 external-priority patent/US9102752B2/en
Application filed filed Critical
Publication of JP2016513638A publication Critical patent/JP2016513638A/ja
Publication of JP2016513638A5 publication Critical patent/JP2016513638A5/ja
Application granted granted Critical
Publication of JP6208319B2 publication Critical patent/JP6208319B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016500078A 2013-03-15 2013-04-23 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン Active JP6208319B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/843,883 2013-03-15
US13/843,883 US9102752B2 (en) 2013-03-15 2013-03-15 Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
PCT/US2013/037865 WO2014143087A1 (en) 2013-03-15 2013-04-23 Peptide vaccine for prevention and immunotherapy of dementia of the alzheimer's type

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017112424A Division JP6784646B2 (ja) 2013-03-15 2017-06-07 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン

Publications (3)

Publication Number Publication Date
JP2016513638A JP2016513638A (ja) 2016-05-16
JP2016513638A5 true JP2016513638A5 (enExample) 2016-06-23
JP6208319B2 JP6208319B2 (ja) 2017-10-04

Family

ID=51527985

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016500078A Active JP6208319B2 (ja) 2013-03-15 2013-04-23 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン
JP2017112424A Active JP6784646B2 (ja) 2013-03-15 2017-06-07 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン
JP2019137534A Pending JP2019196397A (ja) 2013-03-15 2019-07-26 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017112424A Active JP6784646B2 (ja) 2013-03-15 2017-06-07 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン
JP2019137534A Pending JP2019196397A (ja) 2013-03-15 2019-07-26 アルツハイマー型認知症の予防用及び免疫療法用ペプチドワクチン

Country Status (18)

Country Link
US (4) US9102752B2 (enExample)
EP (1) EP2968485B1 (enExample)
JP (3) JP6208319B2 (enExample)
KR (2) KR20180132962A (enExample)
CN (2) CN105228644B (enExample)
AU (3) AU2013381835A1 (enExample)
BR (1) BR112015023105A8 (enExample)
CA (1) CA2906313A1 (enExample)
DK (1) DK2968485T3 (enExample)
ES (1) ES2800028T3 (enExample)
IL (2) IL241597B (enExample)
MX (2) MX364689B (enExample)
PT (1) PT2968485T (enExample)
RU (1) RU2696566C2 (enExample)
SG (1) SG11201507669YA (enExample)
TW (1) TWI561529B (enExample)
WO (1) WO2014143087A1 (enExample)
ZA (2) ZA201507526B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9102752B2 (en) * 2013-03-15 2015-08-11 United Biomedical, Inc. Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
AU2015243990A1 (en) * 2014-04-07 2016-11-10 La Jolla Pharmaceutical Company Hepcidin mimetic peptides and uses thereof
WO2017131468A1 (ko) * 2016-01-27 2017-08-03 경상대학교산학협력단 아디포넥틴 수용체 활성화 신규 펩티드를 유효성분으로 포함하는 신경질환의 예방, 개선 또는 치료용 조성물
EP3444344A4 (en) * 2016-04-14 2020-02-19 TAO Health Life Pharma Co., Ltd. AMYLOSPHEROID TYPE STRUCTURE (ASPD) AND PHARMACEUTICAL COMPOSITION
CN106565847B (zh) * 2016-10-26 2020-12-01 清华大学 化合物、多肽及其用途
MX2019015286A (es) * 2017-06-16 2020-08-17 United Neuroscience Inmunogenos peptidicos del extremo c-terminal de proteinas alfa-sinucleinas y formulaciones de las mismas para el tratamiento de sinucleinopatias.
US11773148B2 (en) * 2017-10-27 2023-10-03 United Neuroscience Tau peptide immunogen constructs
BR112020011308A2 (pt) * 2017-12-11 2020-11-17 Ubi Ip Holdings imunógenos peptídicos de il-31 e formulações dos mesmos para tratamento e/ou prevenção de dermatite atópica
MX2020006937A (es) * 2017-12-31 2020-10-05 United Biomedical Inc Inmunógenos peptídicos y formulaciones de estos dirigidos a la ige unida a la membrana para el tratamiento de enfermedades alérgicas mediadas por ige.
AU2019222707A1 (en) * 2018-02-13 2020-08-13 Cedars-Sinai Medical Center Methods and systems for identification and treatment of pathological neurodegeneration and age-related cognitive decline
WO2019197414A1 (en) 2018-04-10 2019-10-17 Ac Immune Sa Anti-abeta therapeutic vaccines
US20220023400A1 (en) * 2018-05-04 2022-01-27 Ubi Us Holdings, Llc. Artificial promiscuous t helper cell epitopes that facilitate targeted antibody production with limited t cell inflammatory response
TWI676635B (zh) * 2018-06-15 2019-11-11 英屬開曼群島商聯腦科學公司 α-突觸核蛋白C端胜肽免疫原及其用於治療突觸核蛋白疾病的配方
AU2019354291A1 (en) * 2018-10-01 2021-05-06 United Neuroscience Peptide immunogen constructs directed against dipeptide repeat proteins from C9ORF72
JP7555598B2 (ja) * 2018-12-19 2024-09-25 ユナイテッド・バイオメディカル・インコーポレーテッド 合成ペプチド免疫原のための免疫刺激薬としての人工無差別tヘルパー細胞エピトープ
SG11202107042WA (en) * 2018-12-28 2021-07-29 United Biomedical Inc Peptide immunogens targeting interleukin 6 (il-6) and formulations thereof for immunotherapy of diseases impacted by il-6 dysregulation
CA3125674A1 (en) * 2018-12-31 2020-07-09 United Neuroscience Limited Peptide immunogens targeting calcitonin gene-related peptide (cgrp) and formulations thereof for prevention and treatment of migraine
CN110759987B (zh) * 2019-10-29 2021-06-08 中国人民解放军军事科学院军事医学研究院 构象特异性的重组Aβ1-42样寡聚体抗原、其制备方法和应用
CA3168991A1 (en) * 2020-01-23 2021-07-29 United Biomedical, Inc. Peptide immunogens targeting pituitary adenylate cyclase-activating peptide (pacap) and formulations thereof for prevention and treatment of migraine
MX2022011199A (es) 2020-03-10 2022-12-07 Lifearc Peptidos ciclicos.
CA3195783A1 (en) 2020-11-17 2022-05-27 Keith Rubin Treatment and prevention of neuropathology associated with neurodegenerative diseases
EP4307988A4 (en) * 2021-03-16 2025-01-22 NeuroVision Imaging, Inc. BIOFLUID-BASED METHODS FOR DIAGNOSING CONDITIONS ASSOCIATED WITH ALZHEIMER'S DISEASE
US20240358805A1 (en) * 2021-08-30 2024-10-31 The Brigham And Women's Hospital, Inc. Methods and materials to treat neurodegenerative disease
EP4445910A1 (en) 2021-12-08 2024-10-16 Osaka University Vaccine composition for inducing anti-il-23 antibody
US20250186595A1 (en) 2022-02-28 2025-06-12 Tridem Bioscience Gmbh & Co Kg A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN
KR102530956B1 (ko) * 2022-09-08 2023-05-11 주식회사 알츠코리아 아밀로이드 베타 유래 에피토프를 유효성분으로 포함하는 알츠하이머성 치매 백신 조성물 및 이의 용도
CN115417915B (zh) * 2022-11-03 2023-02-24 北京引正基因科技有限公司 多肽载体及其应用
CN117122612B (zh) * 2023-07-07 2024-08-27 河络新图生物科技(上海)有限公司 外周血单个核细胞在制备治疗/预防阿尔茨海默病的药物中的用途
WO2025109524A1 (en) 2023-11-22 2025-05-30 Ac Immune Sa Assays and methods for assessing vaccine preparations

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753624A (en) 1990-04-27 1998-05-19 Milkhaus Laboratory, Inc. Materials and methods for treatment of plaquing disease
JP2980677B2 (ja) 1990-04-27 1999-11-22 マクマイケル,ジョン 不正常なアミロイドβタンパク質と関連する中枢神経系疾患状態の治療のための方法および組成物
EP1308461A3 (en) 1993-01-25 2004-02-11 Takeda Chemical Industries, Ltd. Antibodies to beta-amyloids or their derivatives and use thereof
US5955317A (en) 1993-01-25 1999-09-21 Takeda Chemical Industries, Ltd. Antibodies to β-amyloids or their derivatives and use thereof
US5759551A (en) 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
AU7043894A (en) 1993-05-28 1994-12-20 Miriam Hospital, The Composition and method for (in vivo) imaging of amyloid deposits
AU8091694A (en) 1993-10-26 1995-05-22 United Biomedical Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
US6787523B1 (en) 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
US6750324B1 (en) 1997-12-02 2004-06-15 Neuralab Limited Humanized and chimeric N-terminal amyloid beta-antibodies
US6025468A (en) 1998-06-20 2000-02-15 United Biomedical, Inc. Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
TWI229679B (en) 1998-06-20 2005-03-21 United Biomedical Inc Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
WO2001018169A2 (en) 1999-09-03 2001-03-15 Ramot University Authority For Applied Research & Industrial Development Ltd. Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
ATE344803T1 (de) 1999-12-08 2006-11-15 Intellect Neurosciences Inc Schimärische amyloid-beta peptide
US20030083277A1 (en) * 2000-02-24 2003-05-01 Hersh Louis B. Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients
US20030165481A1 (en) 2000-02-24 2003-09-04 Hersh Louis B. Amyloid peptide inactivating enzyme to treat Alzheimer's disease
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
US8088388B2 (en) 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
JP2006513259A (ja) * 2002-07-24 2006-04-20 イノジェネティックス・ナムローゼ・フェンノートシャップ ベータ−アミロイド生成および/または凝集に関連した疾病の防止、処置および診断
WO2005072777A2 (en) * 2004-01-28 2005-08-11 Curix Aps Conjugates of amyloid proteins as vaccines for amyloid-related diseases
WO2007097251A1 (ja) * 2006-02-22 2007-08-30 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo 抗アミロイドβペプチド抗体産生誘導用のペプチドワクチン
CA2638841A1 (en) * 2006-02-24 2007-08-30 Chiesi Farmaceutici S.P.A. Anti-amyloid immunogenic compositions, methods and uses
WO2008021296A2 (en) 2006-08-14 2008-02-21 Thymon, L.L.C. Compositions and methods for the treatment and prophylaxis of alzheimer's disease
AT506820B1 (de) * 2008-06-12 2011-07-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzine gegen alzheimer-krankheit
EP2342356A4 (en) * 2008-09-29 2012-11-21 Univ Ben Gurion AMYLOID BETA PEPTIDASES AND METHOD OF USE THEREOF
US9067981B1 (en) * 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies
US8916387B2 (en) * 2010-10-28 2014-12-23 Jonas Nilsson Diagnosis and treatment of Alzheimer's disease
US9102752B2 (en) * 2013-03-15 2015-08-11 United Biomedical, Inc. Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type

Similar Documents

Publication Publication Date Title
JP2016513638A5 (enExample)
HRP20220924T1 (hr) Imunoterapija zasnovana na pd-l1
WO2009022215A8 (en) Combination motif immune stimulatory oligonucleotides with improved activity
RU2015142996A (ru) Пептидная вакцина для предупреждения и иммунотерапии деменции альцгеймеровского типа
JP2014534202A5 (enExample)
IL276210B2 (en) Mers-cov vaccine
JP2016502551A5 (enExample)
JP2015214545A5 (enExample)
JP2011250797A5 (enExample)
JP2009539965A5 (enExample)
JP2012176978A5 (enExample)
EA201391240A1 (ru) Слитые белки и комбинированные вакцины, содержащие белок е и пилин а haemophilus influenza
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
WO2009060281A3 (en) Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties
WO2014205317A3 (en) Cyclic peptides as protein targeting agents
JP2015529678A5 (enExample)
RU2020117033A (ru) Комплекс, содержащий олигонуклеотид, обладающий иммуностимулирующей активностью, и его применение
JP2012126742A5 (enExample)
JP2017523985A5 (enExample)
HRP20180282T1 (hr) Imunoterapija na bazi indoleamin 2, 3-dioksigenaze
WO2011094357A8 (en) Respiratory virus epitopes templated into double stranded coiled -coils and use thereof in immunization
JP2017524682A5 (enExample)
SG178904A1 (en) Combination vaccines against respiratory tract diseases
NZ597858A (en) Vaccines and compositions against streptococcus pneumoniae
JP2016509011A5 (enExample)